Cycurion Appeals Nasdaq Delisting; Hearing Set for August 2026

summarizeSummary

Cycurion disclosed it has appealed Nasdaq's delisting determination and will present its compliance plan at a hearing in August 2026. The stock continues to trade on Nasdaq pending the outcome.

check_boxKey Events · Legal and Risk Events · CYCU

• Nasdaq Delisting Appeal Filed

  Cycurion requested a hearing before the Nasdaq Hearings Panel to appeal the delisting determination received on July 10, 2026, for non-compliance with the minimum bid price rule (Rule 5550(a)(1)).

• Hearing Scheduled for August 2026

  The hearing is expected to take place in August 2026. The request has stayed any suspension or delisting action pending the hearing and any extension period granted by the Panel.

• Compliance Plan to Be Presented

  At the hearing, the Company intends to present its plan to regain and maintain compliance with Nasdaq listing standards. No details of the plan were disclosed.

• Stock Continues Trading on Nasdaq

  Cycurion's common stock will continue to trade on The Nasdaq Capital Market under symbol 'CYCU' at least through the hearing and any extension period.

auto_awesomeAnalysis · CYCU · Technology

After receiving a delisting notice on July 10, 2026, for failing the minimum bid price rule, Cycurion is fighting to retain its Nasdaq listing. A hearing has been secured for August 2026, automatically staying any delisting action until the panel rules. This is a critical juncture — losing the listing would severely limit liquidity and access to capital, especially for a company already under going-concern pressure and reliant on equity-linked financing. The hearing is the make-or-break event; the company must present a credible plan to regain compliance, likely through a reverse stock split or sustained price improvement.